| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 肠外营养系(元) | - | - | 206,453,210.64 | 511,933,421.29 | 256,683,503.66 |
| 服务收入(元) | - | - | - | - | 164,047,857.12 |
| 麻醉产品(元) | - | - | 796,479,421.25 | 1,231,651,885.28 | 517,198,642.10 |
| 原料药(元) | - | - | - | - | 317,029,880.69 |
| 肿瘤止吐(元) | - | - | 163,115,730.89 | 305,420,471.07 | 136,040,511.80 |
| 合作产品相关收入(元) | - | - | 471,917,438.75 | 943,165,709.63 | - |
| 合作生产产品(元) | 515,801,448.97 | 1,028,877,857.73 | - | - | - |
| 自主生产产品(元) | 1,783,834,073.23 | 3,278,697,714.25 | - | - | - |
| 其他产品(元) | - | - | 340,477,029.81 | 580,472,122.67 | 282,150,206.20 |
| 其他(元) | - | - | 5,215,083.02 | 120,100,758.58 | - |
| 其他产品(服务)(元) | 778,773,988.30 | 46,595,209.67 | - | - | - |
| 营业成本(元) | |||||
| 肠外营养系(元) | - | - | 90,701,877.17 | 208,270,885.07 | 103,717,622.41 |
| 服务收入(元) | - | - | - | - | 77,478,544.50 |
| 麻醉产品(元) | - | - | 64,237,585.69 | 117,876,830.57 | 53,302,198.53 |
| 原料药(元) | - | - | - | - | 106,319,012.47 |
| 肿瘤止吐(元) | - | - | 19,468,736.16 | 39,732,253.51 | 20,669,080.58 |
| 合作产品相关收入(元) | - | - | 235,348,358.24 | 410,019,623.87 | - |
| 合作生产产品(元) | 289,222,654.39 | 608,491,708.71 | - | - | - |
| 自主生产产品(元) | 312,682,203.86 | 636,464,084.24 | - | - | - |
| 其他产品(元) | - | - | 121,455,766.06 | 220,292,338.37 | 104,898,519.19 |
| 其他(元) | - | - | 1,414,302.85 | 51,868,357.40 | - |
| 其他产品(服务)(元) | 519,848.88 | 3,378,809.51 | - | - | - |
| 毛利(元) | |||||
| 肠外营养系(元) | - | - | 115,751,333.47 | 303,662,536.22 | 152,965,881.25 |
| 服务收入(元) | - | - | - | - | 86,569,312.62 |
| 麻醉产品(元) | - | - | 732,241,835.56 | 1,113,775,054.71 | 463,896,443.57 |
| 原料药(元) | - | - | - | - | 210,710,868.22 |
| 肿瘤止吐(元) | - | - | 143,646,994.73 | 265,688,217.56 | 115,371,431.22 |
| 合作产品相关收入(元) | - | - | 236,569,080.51 | 533,146,085.76 | - |
| 合作生产产品(元) | 226,578,794.58 | 420,386,149.02 | - | - | - |
| 自主生产产品(元) | 1,471,151,869.37 | 2,642,233,630.01 | - | - | - |
| 其他产品(元) | - | - | 219,021,263.75 | 360,179,784.30 | 177,251,687.01 |
| 其他(元) | - | - | 3,800,780.17 | 68,232,401.18 | - |
| 其他产品(服务)(元) | 778,254,139.42 | 43,216,400.16 | - | - | - |
| 毛利率(%) | |||||
| 肠外营养系(%) | - | - | 56.07 | 59.32 | 59.59 |
| 服务收入(%) | - | - | - | - | 52.77 |
| 麻醉产品(%) | - | - | 91.93 | 90.43 | 89.69 |
| 原料药(%) | - | - | - | - | 66.46 |
| 肿瘤止吐(%) | - | - | 88.06 | 86.99 | 84.81 |
| 合作产品相关收入(%) | - | - | 50.13 | 56.53 | - |
| 合作生产产品(%) | 43.93 | 40.86 | - | - | - |
| 自主生产产品(%) | 82.47 | 80.59 | - | - | - |
| 其他产品(%) | - | - | 64.33 | 62.05 | 62.82 |
| 其他(%) | - | - | 72.88 | 56.81 | - |
| 其他产品(服务)(%) | 99.93 | 92.75 | - | - | - |
| 收入构成(%) | |||||
| 肠外营养系(%) | - | - | 10.41 | 13.86 | 15.34 |
| 服务收入(%) | - | - | - | - | 9.80 |
| 麻醉产品(%) | - | - | 40.15 | 33.35 | 30.91 |
| 原料药(%) | - | - | - | - | 18.95 |
| 肿瘤止吐(%) | - | - | 8.22 | 8.27 | 8.13 |
| 合作产品相关收入(%) | - | - | 23.79 | 25.54 | - |
| 合作生产产品(%) | 16.76 | 23.63 | - | - | - |
| 自主生产产品(%) | 57.95 | 75.30 | - | - | - |
| 其他产品(%) | - | - | 17.16 | 15.72 | 16.86 |
| 其他(%) | - | - | 0.26 | 3.25 | - |
| 其他产品(服务)(%) | 25.30 | 1.07 | - | - | - |
| 毛利构成(%) | |||||
| 肠外营养系(%) | - | - | 7.98 | 11.48 | 12.68 |
| 服务收入(%) | - | - | - | - | 7.17 |
| 麻醉产品(%) | - | - | 50.46 | 42.11 | 38.44 |
| 原料药(%) | - | - | - | - | 17.46 |
| 肿瘤止吐(%) | - | - | 9.90 | 10.05 | 9.56 |
| 合作产品相关收入(%) | - | - | 16.30 | 20.16 | - |
| 合作生产产品(%) | 9.15 | 13.54 | - | - | - |
| 自主生产产品(%) | 59.42 | 85.07 | - | - | - |
| 其他产品(%) | - | - | 15.09 | 13.62 | 14.69 |
| 其他(%) | - | - | 0.26 | 2.58 | - |
| 其他产品(服务)(%) | 31.43 | 1.39 | - | - | - |